EVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS - Egyptian Knowledge Bank - troweb

30725

EVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS

Article

Last updated: 22 Jan 2023

Overview Similar Items

Article

SERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Article

Assessment of Interleukin-34 Serum level In Children with Systemic lupus Erythematosus

Article

ROLE OF INTERLEUKIN-23 AS A MARKER OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS

Article

Serum Interleukin-33 in Rheumatoid Arthritis and its Relation to Disease Activity

Article

Interleukin-33 as a marker for disease activity in rheumatoid arthritis

Article

Clinical Association of Serum Interleukin-17 and Interleukin-6 in Systemic Lupus Erythematosus Patients

Article

Evaluation of Interleukin-9 Serum Level and Gene Polymorphism in A Sample of Systemic Lupus Erythematosus in Iraqi Female's Patients

Article

Serum Interleukin-17 Level in Patients with Rheumatoid Arthritis and its Relation to Disease Activity

Article

EVALUATION OF SERUM INTERLEUKIN 15 IN PSORIATIC PATIENTS

Article

Serum Level Of Interleukin-23 in patients with Juvenile Idiopathic Arthritis and correlation to Disease Activity